Skip to main content
Download PDF

Dietary advanced glycation end products are associated with an increased risk of breast cancer in Iranian adults

BMC Cancer volume 23, Article number: 932 (2023) Cite this article

Abstract

Background

Dietary advanced glycation end products (AGEs) can play an important role in increasing inflammatory factors and oxidative stress as risk factors for cancers. In the present study, we aimed to assess the relationship between dietary AGEs and the risk of breast cancer (BC) in Iranian adult women.

Methods

This hospital-based case-control study includes 401 participants aged ≥ 30 years old. The cases group consisted of 134 women diagnosed with histologically confirmed BC. The control group included 267 women enrolled randomly from patients admitted to the same hospitals. Dietary intake information was determined using a validated food frequency questionnaire, and dietary AGEs intake was computed for all participants. Logistic regression models, adjusted for potential confounders, were used to determine the odds ratios (OR) and 95% confidence interval (CI) of BC across tertiles of dietary AGEs.

Results

The mean ± SD age and body mass index of the study population were 47.92 ± 10.33 years and 29.43 ± 5.51 kg/m2, respectively. The median (interquartile) of dietary AGEs in all individuals was 9251(7450, 11,818) kU/day. After adjusting for age, first pregnancy age, and energy intake, participants in the highest tertile of dietary AGEs intakes had higher odds of BC compared to those in the lowest tertile of dietary AGEs (OR:2.29;95%CI:1.19–4.39, Ptrend:0.012). Additionally, in the multivariable model, after adjusting for age, age at first pregnancy, energy, menopausal status, family history of cancer, anti-inflammatory drug use, Vitamin D supplementation, physical activity, body mass index, number of childbirths, and history of abortion, breastfeeding, and oral contraceptive pills use, the odds of BC were increased across tertiles of dietary AGEs intake (OR: 2.33; 95%CI: 1.18–4.60, Ptrend: 0.017).

Conclusion

The present findings suggest that a diet with high AGEs is associated with a higher likelihood of BC in adult women.

Peer Review reports

Introduction

Breast cancer (BC) is the leading cause of global cancer incidence with 2.3 million new cases reported in 2020 accounting for one in six cancer deaths among women worldwide [1]. In Iran, BC is the most common cancer and the fifth cause of death related to cancers among women with a prevalence of 23.6% [2, 3]. The most important factors related to BC are age, genetic susceptibility, reproductive parameters, estrogen, elevated body mass index (BMI), and lifestyle [4, 5]. While genetic predisposition is important, up to 34% of BC cases can be prevented by modifying lifestyle factors such as physical activity, diet, alcohol consumption, and body weight [6].

Nutrition is one of the important and modifiable aspects of lifestyle that plays a role in the etiology of BC [7, 8]. A recent umbrella review found that higher consumption of red or processed meats, foods with a high glycemic index, and eggs were associated with a higher risk of BC, while the consumption of plant-based foods and nutrients such as calcium, vitamin D, folate, lignans, and carotenoids were inversely associated with BC risk [9]. Advanced glycation end products (AGEs) are other dietary components that their possible role in the pathogenesis of chronic diseases such as BC has recently warranted attention. These harmful products are mostly produced as a result of the thermal processing of animal-derived foods during food processing and cooking at high temperatures, such as deep frying, grilling, or broiling [10, 11]. AGEs are formed from the non-enzymatic reaction between reducing sugars and free amino groups of proteins, lipids, or nucleic acids and possess pro-oxidant properties in foods [12]. Carboxymethyl lysine (CML), which is mainly used as a dietary AGEs indicator, is one of the most important types of AGEs [13].

High intake of dietary AGEs has a positive effect on the serum level of these products in the body, aggravating inflammatory conditions and oxidative stress, and contributing to metabolic disorders [14,15,16,17,18]. In-vitro and in-vivo evidence and experimental studies show that AGEs can promote carcinogenesis and primary cancer cells through the formation of reactive oxygen species (ROS) and increased inflammation [19, 20]. Also, limited epidemiological studies have investigated the relationship between dietary AGEs and the risk of BCs [21, 22]; a large cohort study reported a 30% higher risk of developing BC in women consuming food with high content of dietary AGEs [21]. Also, another study on postmenopausal women found a 9% higher risk of BC in women who were in the highest quintile of AGEs intake [22].

It is important to note that the above-mentioned studies were conducted in Western countries, which have different eating habits and dietary patterns as well as different incidence rates of BC than developing countries in the Middle East and North Africa (MENA) region, such as Iran. In comparison to the USA and European countries, the incidence of BC in MENA region countries is lower, however, is steadily increasing. Also, BC patients in low-income countries still bear a greater burden of BC mortality [5, 23]. In the past decades, in European and North American countries, the common food patterns in individuals were rich in simple sugars, saturated fat, trans fatty acids, and sodium, which made them susceptible to chronic diseases, such as cancers; however, in recent years, the MENA region undergone a shift from the traditional healthy diet towards a more westernized diet rich in energy-dense foods, sweetened beverages, saturated fat, processed foods, and food items containing high levels of AGEs, which can affect the incidence of nutrition-related chronic diseases, such as cancers [24, 25]. Therefore, this study aimed to investigate the association between dietary AGEs intake and odds of BC in a sample of Iranian adult women, making it the first study in the MENA region to explore this relationship.

Materials and methods

Study population

This hospital-based case-control study was conducted at Shohada and Imam Hossain hospitals, which are referral hospitals in Tehran, Iran. The study was performed from September 2015 to February 2016. The case group consisted of newly diagnosed BC patients aged ≥ 30 years, who were selected from patients diagnosed with BC less than 6 months ago. Eligible participants in the case group included incident cases diagnosed with histologically confirmed BC in the past 6 months, who did not undergo any cancer treatments at the time of the interview, and who had proper general condition. Various exclusion criteria, including following special dietary habits such as vegetarianism, history of hormone replacement therapy (HRT), and being pregnant or lactating were considered for the selection of the final study population for the case group. For the control group, we also considered the various exclusion criteria, including history of HRT and benign breast disease, history of physician-diagnosed cancer in any site, pregnancy or lactating status, and following special dietary habits due to a particular disease or weight loss. Two controls were selected for each case in this study, and we randomly enrolled women admitted to the same hospitals, at the same time and same age (± 5year). The control group had been hospitalized mainly due to conditions such as traumas and orthopedic disorders, disk disorders, acute surgical conditions, and eye, ear, nose, or skin disorders.

The participation rate for all invited patients was 92%, with a rate of 95% for the case group and 89% for the control group. Of the 408 eligible subjects considered for this study, seven subjects were excluded as their energy intake was away from ± 3 standard deviations (SD) of the mean energy intake of the population. Among these excluded subjects, two were from the case group and five were from the control group. Finally, 401 women (134 cases and 267 controls) were included in the final analysis.

Dietary assessment

Dietary intake data for cases and controls were collected by a trained dietician using a valid and reliable semi-quantitative 168-item food frequency questionnaire (FFQ) during a face-to-face interview [26]. To assess dietary intakes, a trained dietician asked participants that provide their daily, weekly, monthly, or yearly consumption frequency for each food item according to the standard portion size; then, these frequencies were transformed into grams per day using the household measure [27]. The participants’ energy, macronutrients, and micronutrient intake were computed using the USDA food composition table (FCT). For traditional food items that did not exist in the USDA database, we used Iranian FCT [28].

Calculation of dietary AGEs intake

The dietary AGEs intake of participants (kU/day) was calculated using AGEs content in 108 food items from the 168-FFQ based on the studies conducted by Goldberg et al. [13] and Uribarry et al. [10]. To measure the total AGEs intake, we calculated the AGEs content (kU/100 g) of each food item in our FFQ based on these studies. For some traditional foods, we considered similar items found in these above-mentioned studies. Finally, we summed the AGEs value of all food items for each person as their total daily dietary AGEs intake.

Assessment of non-dietary exposures

Participants’ weight was measured with minimal clothes and without shoes with a digital scale (Seca, Germany) with an accuracy of 100 g. We also measured the height of the participants in a standing position without shoes using a stadiometer to the nearest 0.5 cm. BMI was calculated by dividing weight (kg) by height squared (m2).

An expert nutritionist used a standard questionnaire to collect data on various variables, including age, smoking, education level, marital status, age at menarche, age at first pregnancy, abortion history, number of live births, menopausal status, breastfeeding history, history of hormone replacement therapy, history of oral contraceptive pills (OCP) use, benign breast diseases history, cancer family history, bra-wearing habits, family history of BC, supplement intake, and anti-inflammatory medication use. Information on physical activity (PA) levels was obtained by a valid and reliable questionnaire [29] and reported as Metabolic Equivalents per week (METs/week) [30, 31].

We determined participants’ socioeconomic status (SES) score [32] based on five dichotomous variables scored as 0 or 1: education (academic = 1, non-academic education = 0), family size (≤ 4 people = 1, >4 people = 0), income (high = 1, moderate and low = 0), house acquisition (house ownership = 1, without personal housing = 0), and foreign travel (yes = 1, no = 0). We then calculated the total SES score by summing the assigned scores (minimum SES score of 0 to maximum score of 5). An SES score of 3, 4, and 5 was categorized as high, 2 as moderate, and 1 or 0 as low.

Statistical analysis

Statistical analysis was performed using Statistical Package Software for Social Science, version 21 (SPSS Inc., Chicago, IL, USA). The Student’s t-test and analysis of variance (ANOVA) were used to compare mean values for normally distributed variables, while the Mann–Whitney U test and Kruskal–Wallis test were used to compare variables without a normal distribution. The Chi-square test was used to compare the differences between cases and controls for categorical variables. Participants were categorized into tertiles based on cut points of dietary AGEs intake. Logistic regression was used to calculate the odds ratio (OR) and 95% confidence interval (95% CI) of BC according to the tertiles of the dietary AGEs intake. The multivariable logistic regression model was adjusted for age, age at first pregnancy, energy, menopausal status, family history of cancer, anti-inflammatory drug use, Vitamin D supplementation, physical activity, BMI, number of childbirths, and history of abortion, breastfeeding, OCP use. Since the etiology of BC can vary greatly according to menopausal status, we also conducted a subgroup analysis based on menopausal status and assessed the association between AGEs (per increment of each SD) and odds of BC in the pre-and post-menopausal women. All P-values are two-sided, and P-values < 0.05 were considered significant.

Results

The mean age and BMI of all participants were 47.92 ± 10.33 years and 29.43 ± 5.51 kg/m2, respectively. Among the case and control groups, the mean age was 49.50 ± 10.67 and 47.13 ± 10.08 years, respectively. The median (interquartile) intake of dietary AGEs was 9451 (7803–11,855) kU/day for the case group and 9134 (7178–11,786) kU/day for the control group. The median intake of dietary AGEs across tertiles was 6594, 9125, and 13,628 kU/day, respectively.

Table 1 shows the study population characteristics based on the tertiles of dietary AGEs. Our findings indicated that the mean age of participants in the third tertile of AGEs was lower than those in the first tertile. However, there was no significant difference in various variables, including first pregnancy age, BMI, PA, smoking, marital status, menopausal status, cancer family history, anti-inflammatory drugs, breastfeeding history, education level, occupation status, family size, and SES across tertiles of dietary AGEs intake. Also, according to Table 1, the intakes of energy, fat, PUFA, MUFA, and SFA increased across tertiles of dietary AGEs intake, whereas the intakes of carbohydrate, protein, and fiber decreased across tertiles of dietary AGEs intake.

Table 1 Study population characteristics based on the tertiles cut points of dietary advanced glycation end products
Full size table

Table 2 reported the population characteristics, including demographic data, anthropometric measures, clinical features, and dietary intakes of BC patients (case group) and healthy participants (control group). The mean age and percentage of menopausal status, and cancer family history were higher in the case group compared to the control group, whereas the percentage of vitamin D supplement intake and anti-inflammatory drug use was lower in the case group compared to the control group. However, there was no significant difference between the case and control groups in first pregnancy age, mean BMI, PA level, smoking status, marital status, percentage of men, breastfeeding history, education level, occupation status, family size, and SES. Table 2 indicated that the energy intake was higher in the control group compared to the case group, but, no significant difference was observed in other dietary intakes between the two groups.

Table 2 Study population characteristics among the breast cancer patients and healthy participants
Full size table

The ORs and 95% CIs for BC across tertiles of AGEs are presented in Table 3. In the crude mode, there was no significant association between dietary AGEs intakes and risk of BC (OR: 1.22; 95%CI: 0.71–2.07, P for trend: 0.459). However, in model 2, after adjusting for age, first pregnancy age, and energy intake, the odds of BC increased noticeably across tertiles of the dietary AGEs intakes (OR: 2.29; 95%CI: 1.19–4.39, P for trend:0.012). Also, in the final model, an additional adjustment for menopausal status, family history of cancer, anti-inflammatory drug use, Vitamin D supplementation, physical activity, BMI, number of childbirths, and history of abortion, breastfeeding, and OCP use, the odds of BC in participants in the highest tertile of dietary AGEs intakes were higher than those in lowest tertile (OR: 2.33; 95%CI: 1.18–4.60, P for trend: 0.017).

Table 3 Odds ratios (ORs) and 95% confidence intervals (CIs) for breast cancer based on tertiles of dietary advanced glycation end products (AGEs)
Full size table

Table 4 reported the ORs and 95% CIs for BC based on tertiles of dietary AGEs from different food sources, including meats, dairy products, cereals, oil, vegetables, fruits, nuts, legumes, and sweets. In the fully adjusted regression model, after adjusting for age, first pregnancy age, energy intake, menopausal status, family history of cancer, anti-inflammatory drug use, Vitamin D supplementation, physical activity, BMI, number of childbirths, and history of abortion, breastfeeding, and OCP use, participants in the highest tertile of dietary AGEs from oil had a higher odds of BC than those in the lowest tertile (OR: 3.18; 95%CI: 1.69–5.98, P for trend < 0.001). Also, a direct relationship between dietary AGEs from meat (OR: 1.04), dairy products (OR: 1.49), sweets (OR: 1.17), and cereals (OR: 1.25), and the risk of BC was observed, although it was not statistically significant. The results regarding the association of dietary AGEs from fruits, vegetables, legumes, and nuts with the risk of BC were not statistically significant.

Table 4 Odds ratios (ORs) and 95% confidence intervals (CIs) for breast cancer based on tertiles of dietary advanced glycation end products (AGEs) from different food sources
Full size table

Furthermore, in a subgroup analysis based on the menopausal status, we assessed the association of AGEs (per increment of each SD) and odds of BC in the pre-and post-menopause women. Table 5 showed that in post-menopause women, in the multi-variables model, there was a direct association between per increment of each SD dietary AGEs intake and increased odds of BC (OR: 1.70; 95%CI: 1.11–2.60, P for trend: 0.014). However, in pre-menopause women, no significant association was observed between dietary AGEs intake and odds of BC.

Table 5 Odds ratios (ORs) and 95% confidence intervals (CIs) for breast cancer per each SD increase in dietary advanced glycation end products (AGEs) based on menopausal status
Full size table

Discussion

The present study is the first study in Iranian women that showed a positive association between dietary AGEs intake and the risk of BC. The higher risk of BC across tertiles of dietary AGEs was strengthened after adjusting for various confounding factors.

Our finding is in line with the results from previous limited studies conducted on different populations, which assessed the possible association of dietary AGEs or its serum level with the risk of BC or its mortality [21, 22, 33, 34]. A prospective cohort study on 183,548 postmenopausal women showed a positive role of higher dietary AGEs intake in the progression of BC in the postmenopausal phase [22]. Similarly, Omofuma et al. reported that women with a higher intake of dietary AGEs may be more at risk of developing BC [21]. Also, according to the findings of a prospective women’s health initiative study, higher dietary AGEs intake may be related to increased premature death and mortality in postmenopausal women with BC [33]. Furthermore, Pan et al. have reported a positive correlation between serum AGEs levels and metastasis of BC [34]. Therefore, the results of the studies conducted in developed countries, as well as the findings of our study, support the suggestion that reducing the intake of dietary AGEs through dietary pattern modification as a main part of the lifestyle can be an important preventive action in women to reduce the risk of the occurrence of BC or prevention of its progress. This suggestion is also mentioned in the study by Walter et al., which reported that regarding the links between lifestyle, AGEs, and diseases, reducing the exposure to AGEs along with lifestyle modification were preventive and treatment options in patients with BC [35].

The adverse role of AGEs and their involvement as an important contributor to cancer initiation and advancement can be explained by some possible mechanisms. As mentioned earlier, AGEs production is the result of glycation and oxidation of proteins and lipids. Binding AGEs to their receptors (RAGE) leads to the activation of some signaling pathways, including nuclear factor (NF)-kB and phosphoinositide 3-kinase (PI3K)/Akt, which can contribute to the development of chronic diseases, such as cancers [36]. AGEs can also produce ROS, create free radicals, and be involved in auto-oxidation reactions [37]. At the cellular level, this can lead to an imbalance between ROS and antioxidant defense, which results in oxidative stress via the accumulation of free radicals. The free radicals cause structural modification in DNA, proteins, lipids, therefore, changing their biological features and, initiating tumor progression, and increasing the risk of cancers [38, 39]. Logsdon et al. showed that the expression of RAGE is highly elevated in breast tumors [40]. Additionally, the proliferation and invasion of BC cells are the results of enhanced expression of RAGE [41, 42].

Overall, various food items, consumed as part of an individual’s dietary pattern, can contribute to an increased pool of AGE within the body [10, 43, 44]. An increase in NƐ- CML as a marker of circulating AGEs has been observed in BC tissues [45], and serum levels of CML are elevated in women diagnosed with BC [34]. An unhealthy lifestyle, which includes a poor diet rich in sugar, animal protein, and fat, along with lower consumption of fruits, whole grains, and vegetables can lead to AGE accumulation and increase the risk of chronic diseases [10, 46,47,48]. Our study indicated that high intake of AGEs from oils can increase the chance of BC. On the other hand, although the results regarding the relationship between dietary AGEs intake from meat, cereals, and dairy products and the risk of BC were not statistically significant, the value of reported ORs (> 1.00) suggests that the cumulative effect of dietary intake of these food groups can make population susceptible to BC. Moreover, we found that a higher percentage of fat intake was associated with higher AGEs intake, consistent with the fact that foods with higher amounts of fat contain more AGEs [10]. Conversely, advancing in tertiles of dietary AGEs intake was associated with a lower percentage of carbohydrate consumption from total dietary energy intake. This may be due to the assumption that carbohydrates with higher water content and health-friendly agents such as vitamins and antioxidants have a lower amount of AGEs [10]. These findings are consistent with the Mirmiran et al. report [18], which showed the same result on the association between dietary AGEs intake and carbohydrates and fat intake.

Given the adverse effects of AGE intake on health, lifestyle modification, including increasing levels of exercise and adhering to a healthy diet, have been reported as effective strategies for reducing the level of circulating AGEs in patients with BC. To reduce the level of circulating AGEs in individuals and mitigate their detrimental effects, several recommendations can be prescribed by nutritionists and dieticians. These recommendations include increasing the consumption of food items with low AGEs content, such as whole grains, fruits, vegetables, legumes, seafood, and low-fat dairy, and also lowering the consumption of food items with higher AGEs content, such as sugar-added food items (i.e. candy, cookies, and beverages), highly processed foods (i.e. processed meats, packaged cheese, and snack-type foods) and high-fat foods (including butter, full-fat cheeses, and fried foods). In addition to dietary modifications, changing cooking methods, such as preferring those with low temperatures and high moisture (e.g., boiling, steaming, poaching, and stewing for a relatively long duration), can also help to reduce the level of AGEs in the body. Appropriate modification in lifestyle behaviors, such as increasing physical activity, reducing body weight, and avoiding smoking can also help to reduce the level of AGEs in the body and prevent possible damages caused by them [18, 49].

In the current study, according to baseline results, there was no significant difference in mean BMI according to the tertiles of dietary AGEs intake. Also, there was no significant difference in the mean BMI of the participants between the case and control groups. So, the baseline results for BMI level in Tables 1 and 2 showed that although the level of BMI in the participants is at a high level, it seems that its effect in predicting the risk of BC may be similar across different tertiles of AGEs intake in the current study. It is worth noting that, considering the evidence extracted from the literature review, high BMI is a key predicting factor in the risk of BC in women, and therefore, we adjusted the effect of BMI in the study analyses as an important confounder. Also, given that the role of BMI in predicting the risk of BC in pre-menopausal and post-menopausal women may be different [50,51,52], we performed a subgroup analysis of participants based on menopausal status. In the multi-variables adjusted model, we observed a direct association between per increment of each SD dietary AGEs intake and increased odds of BC in post-menopause women, however, in pre-menopause women, no significant association was observed between dietary AGEs intake and odds of BC. These findings are in line with the results of the previous investigation that reported an increased risk of BC with an increase in BMI in post-menopausal women [51,52,53]. It is suggested that in postmenopausal women, an increase in BMI is strongly related to an increase in fat mass, whereas it is unlikely that this individual is very muscular. Also, the high risk of BC among postmenopausal women with elevated BMI levels may mainly be associated with an increase in estrogens [53]; this hormonal response may stimulate more estrogen-sensitive breast tissues that may already have a propensity for hyperstimulation, subsequently play a possible role in the promotion of the formation and development of malignant cells [52, 54].

The nature of the case-control study design raises the possibility that individuals with breast cancer (BC) change their food intake and pattern after the diagnosis of their clinical problem. To avoid this bias, we included only newly diagnosed BC patients (new cases) in this study that did not have the opportunity to change their lifestyle, such as dietary pattern for BC management. It is also necessary to mention that we collected nutritional data in BC patients for the last year before the disease was diagnosed in them so that we can have a more appropriate and accurate estimation of their dietary pattern as an essential exposure for BC risk. One issue worth discussing is whether using an FFQ to collect dietary intake data for the last year of patients can show their dietary pattern for at least the last 5–10 years, which may have a significant role in predicting the risk of BC as an important part of an individual’s lifestyle; in response to this question, it should be explained that previous studies in nutritional epidemiology suggest that dietary intake does not change much in less than 5–10 years in adults [51], therefore, using an FFQ can provide an appropriate estimate of long term food intakes and dietary pattern of individuals [50], and allow us to determine the potential role of different aspects of dietary patterns in predicting chronic diseases risk (such as BC in the present study) after adjusting for the effect of confounding factors.

The present study has several strengths. It is the first study in the MENA region to investigate the relationship between dietary AGEs and the risk of BC in adult women. We used valid and reliable questionnaires for dietary intake and PA level assessments, which reduced measurement error. Also, we controlled for and adjusted the confounding effect of various variables in assessing the relationship between dietary AGEs and BC risk. We should consider several limitations as well. First, there is no database regarding the AGEs content of different Iranian foods, so the American database was used. Second, we did not collect data on different cooking methods that can affect the AGEs content of foods. Furthermore, the serum level of AGEs in the subjects was not available, which could have been helpful in estimating the possible effect of dietary AGEs intake on the serum level of AGEs in the study population. Because of religious considerations, alcohol drinking is unusual in the Iranian people, so we couldn’t collect data on alcohol consumption in participants, however, it should be noted that generally, alcohol consumption in women has a very low prevalence in our society. Due to the case-control nature of the study, reverse causality can somewhat occur. In the current study, similar to several other epidemiologic studies, the ELISA method has been used to measure AGEs in food samples. Although a vast body of literature supports the validity and reliability of this method, other methods, such as the ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) approach, have been developed to determine dietary AGEs that may show greater accuracy in estimating their dietary content. The subjects selected for the case group may have made changes in nutritional and non-nutritional exposures (such as BMI and PA) under the influence of their disease; however, to minimize these limitations, the individuals selected for the case group were subjects who on newly (< 6 months) diagnosed with BC, therefore, it is expected these participants mostly have not noticeable changes in their nutritional or non-nutritional characteristics arbitrarily or based on the order of physicians. Moreover, the consideration of various inclusion and exclusion criteria has led to individuals in the case and control groups not being significantly different in most characteristics (as shown in Tables 1 and 2). The use of multivariable regression analysis, adjusted for the confounding effect of various variables, is another help to reduce these limitations in the present study. Finally, despite adjusting the effect of various confounders in the final analysis, the confounding effect of some variables that were not measured or known could not be controlled.

Conclusions

Our results reported that a dietary pattern with high AGEs was associated with increased odds of BC in Iranian adult women. This is a very important result since it can help introduce a dietary pattern that focuses on food components with little or no AGEs, which can be easily adhered to by the public to prevent the occurrence of chronic diseases such as BC.

Data Availability

The datasets analyzed in the current study are available from the corresponding author on reasonable request.

Abbreviations

AGEs:

Dietary advanced glycation end products

ANOVA:

analysis of variance

BC:

breast cancer

BMI:

body mass index

CIs:

confidence intervals

CML:

carboxymethyl-lysine

FCT:

Food Composition Table

FFQ:

food frequency questionnaire

METs:

Metabolic Equivalents

NF:

nuclear factor

OCP:

oral contraceptive pills

ORs:

odds ratios

PA:

physical activity

PI3K:

phosphoinositide 3-kinase

RAGE:

Receptor for AGE

SES:

socioeconomic status

SPSS:

Statistical Package Software for Social Science

USDA:

United States Department of Agriculture

WHR:

waist-hip ratio

References

  1. Sung H, Ferlay J, Siegel RL et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries, Cancer J Clin, vol 71, no. 3, pp. 209–49.

  2. Kazeminia M, Salari N, Hosseinian-Far A, Akbari H, Bazrafshan M-R, Mohammadi M. The prevalence of breast Cancer in iranian women: a systematic review and Meta-analysis, Indian J Gynecologic Oncol, vol 20, no. 1, p. 14.

  3. Farhood B, Geraily G, Alizadeh A. Incidence and mortality of various cancers in Iran and compare to other countries: a review article, Iran J Public Health, vol 47, no. 3, pp. 309–16.

  4. Sun YS, Zhao Z, Yang ZN et al. Risk factors and preventions of breast Cancer, Int J Biol Sci, vol 13, no. 11, pp. 1387–97.

  5. Abdul-Khalek RA, Abu-Sitta G, El Achi N et al. “Mapping breast cancer journal publications in conflict settings in the MENA region: a scoping review,“ Ecancermedicalscience, vol 14, p. 1129.

  6. Cifu G, Arem H. Adherence to lifestyle-related cancer prevention guidelines and breast cancer incidence and mortality, Ann Epidemiol, vol 28, no. 11, pp. 767 – 73.e1.

  7. De Cicco P, Catani MV, Gasperi V, Sibilano M, Quaglietta M, Savini I. Nutrition and breast Cancer: a Literature Review on Prevention, Treatment and Recurrence, Nutrients, vol 11, no. 7.

  8. Ferrini K, Ghelfi F, Mannucci R, Titta L. “Lifestyle, nutrition and breast cancer: facts and presumptions for consideration,“ Ecancermedicalscience, vol 9, p. 557.

  9. Buja A, Pierbon M, Lago L, Grotto G, Baldo V. “Breast Cancer Primary Prevention and Diet: An Umbrella Review” vol 17, no. 13.

  10. Uribarri J, Woodruff S, Goodman S et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet, J Am Diet Assoc, vol 110, no. 6, pp. 911 – 16.e12.

  11. Poulsen MW, Hedegaard RV, Andersen JM et al. Advanced glycation endproducts in food and their effects on health, Food Chem Toxicol, vol 60, pp. 10–37.

  12. Cai W, Gao Q-d, Zhu L, Peppa M, He C, Vlassara H. Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction, Mol Med, vol 8, no. 7, pp. 337–46.

  13. Goldberg T, Cai W, Peppa M et al. Advanced glycoxidation end products in commonly consumed foods, J Am Diet Assoc, vol 104, no. 8, pp. 1287–91.

  14. Uribarri J, del Castillo MD, de la Maza MP et al. Dietary advanced glycation end products and their role in health and disease, Adv Nutr, vol 6, no. 4, pp. 461–73.

  15. Davis KE, Prasad C, Vijayagopal P, Juma S, Adams-Huet B, Imrhan V. Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat, Br J Nutr, vol 114, no. 11, pp. 1797–806.

  16. Uribarri J, Woodruff S, Goodman S et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet, J Am Diet Assoc, vol 110, no. 6, pp. 911–6. e12.

  17. Angoorani P, Ejtahed H-S, Mirmiran P, Mirzaei S, Azizi F. Dietary consumption of advanced glycation end products and risk of metabolic syndrome, Int J Food Sci Nutr, vol 67, no. 2, pp. 170–6.

  18. Mirmiran P, Yousefi R, Mottaghi A, Azizi F. Advanced glycation end products and risk of hypertension in iranian adults: Tehran lipid and glucose study, J Res Med Sci, vol 23, p. 43.

  19. Schröter D, Höhn A. Role of Advanced Glycation End Products in Carcinogenesis and their therapeutic implications, Curr Pharm Design, vol 24, no. 44, pp. 5245–51.

  20. Lee KJ, Yoo JW, Kim YK, Choi JH, Ha T-Y, Gil M. Advanced glycation end products promote triple negative breast cancer cells via ERK and NF-κB pathway, Biochem Biophys Res Commun, vol 495, no. 3, pp. 2195–201.

  21. Omofuma OO, Turner DP, Peterson LL. Dietary Advanced glycation end-products (AGE) and risk of breast Cancer in the prostate, lung, colorectal and ovarian Cancer Screening Trial (PLCO), vol 13, no. 7, pp. 601–10.

  22. Peterson LL, Park S, Park Y, Colditz GA, Anbardar N, Turner DP. “Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study,“ Cancer, vol 126, no. 11, pp. 2648-57.

  23. Bellanger M, Zeinomar N, Tehranifar P, Terry MB. Are global breast cancer incidence and mortality patterns related to country-specific economic development and prevention strategies? J Global Oncol.

  24. Naja F, Nasreddine L, Awada S, El Sayed Ahmad R, Hwalla N. Nutrition in the prevention of breast Cancer: a middle eastern perspective, Front Public Health, vol 7, p. 316.

  25. Sibai AM, Nasreddine L, Mokdad AH, Adra N, Tabet M, Hwalla N. Nutrition transition and cardiovascular disease risk factors in Middle East and North Africa countries: reviewing the evidence, Annals of Nutrition and Metabolism, vol 57, no. 3–4, pp. 193–203.

  26. Asghari G, Rezazadeh A, Hosseini-Esfahani F, Mehrabi Y, Mirmiran P, Azizi F. Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran lipid and glucose study, Br J Nutr, vol 108, no. 6, pp. 1109–17.

  27. Ghaffarpour M, Houshiar-Rad A, Kianfar H. The manual for household measures, cooking yields factors and edible portion of foods, Tehran: Nashre Olume Keshavarzy, vol 7, no. 213, pp. 42–58.

  28. Azar M, Sarkisian E. Food composition table of Iran: National Nutrition and food research institute, Shaheed Beheshti University, Tehran.

  29. Aadahl M, Jørgensen T. Validation of a new self-report instrument for measuring physical activity, Med Sci Sports Exerc, vol 35, no. 7, pp. 1196–202.

  30. Ainsworth BE, Haskell WL, Whitt MC et al. Compendium of physical activities: an update of activity codes and MET intensities, Med Sci Sports Exerc, vol 32, no. 9; SUPP/1, pp. S498–S504.

  31. Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the international physical activity questionnaire short form (IPAQ-SF): a systematic review, Int J Behav Nutr Phys Activity, vol 8, no. 1, pp. 1–11.

  32. Garmaroudi GR, Moradi A. Socio-economic status in Iran: a study of measurement index, Payesh (Health Monitor), vol 9, no. 2, pp. 137–44.

  33. Omofuma OO, Peterson LL, Turner DP et al. Dietary Advanced Glycation End-Products and Mortality after Breast Cancer in the Women’s Health Initiative, Cancer Epidemiol Biomarkers Prev, vol 30, no. 12, pp. 2217–26.

  34. Pan S, Guan Y, Ma Y et al. Advanced glycation end products correlate with breast cancer metastasis by activating RAGE/TLR4 signaling, BMJ Open Diabetes Res Care, vol 10, no. 2.

  35. Walter KR, Ford ME, Gregoski MJ et al. Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention, Breast Cancer Res Treat, vol 173, no. 3, pp. 559–71.

  36. Dariya B, Nagaraju GP. Advanced glycation end products in diabetes, cancer and phytochemical therapy, Drug Discov Today, vol 25, no. 9, pp. 1614–23.

  37. Hayyan M, Hashim MA, AlNashef IM. Superoxide Ion: Generation and Chemical Implications, Chem Rev, vol 116, no. 5, pp. 3029–85.

  38. Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions, J Carcinog, vol 5, p. 14.

  39. Liou GY, Storz P. Reactive oxygen species in cancer, Free Radic Res, vol 44, no. 5, pp. 479–96.

  40. Logsdon CD, Fuentes MK, Huang EH, Arumugam T. RAGE and RAGE ligands in cancer, Curr Mol Med, vol 7, no. 8, pp. 777–89.

  41. Sharaf H, Matou-Nasri S, Wang Q et al. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231, Biochim Biophys Acta, vol 1852, no. 3, pp. 429–41.

  42. Nankali M, Karimi J, Goodarzi MT et al. Increased expression of the receptor for Advanced Glycation End-Products (RAGE) is Associated with Advanced breast Cancer Stage, Oncol Res Treat, vol 39, no. 10, pp. 622–8.

  43. Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects, Ann N Y Acad Sci, vol 1043, no. 1, pp. 461–6.

  44. Vlassara H. Advanced glycation in health and disease: role of the modern environment, Ann N Y Acad Sci, vol 1043, no. 1, pp. 452–60.

  45. Nass N, Ignatov A, Andreas L, Weißenborn C, Kalinski T, Sel S. Accumulation of the advanced glycation end product carboxymethyl lysine in breast cancer is positively associated with estrogen receptor expression and unfavorable prognosis in estrogen receptor-negative cases, Histochem Cell Biol, vol 147, no. 5, pp. 625–34.

  46. Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects, Ann N Y Acad Sci, vol 1043, pp. 461–6.

  47. Vlassara H. Advanced glycation in health and disease: role of the modern environment, Ann N Y Acad Sci, vol 1043, pp. 452–60.

  48. Uribarri J, Cai W, Peppa M et al. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging, J Gerontol A Biol Sci Med Sci, vol 62, no. 4, pp. 427–33.

  49. Palimeri S, Palioura E, Diamanti-Kandarakis E. “Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management,“ Diabetes, metabolic syndrome and obesity: targets and therapy, pp. 415 – 26.

  50. Thompson FE, Subar AF. “Dietary assessment methodology,“ Nutrition in the Prevention and Treatment of Disease, pp. 5–48.

  51. Willett W. Nutritional epidemiology, 3. ; New York: Oxford University Press USA; 2013.

    Google Scholar 

  52. Chen Y, Liu L, Zhou Q et al. Body mass index had different effects on premenopausal and postmenopausal breast cancer risks: a dose-response meta-analysis with 3,318,796 subjects from 31 cohort studies, BMC Public Health, vol 17, no. 1, p. 936.

  53. Group EHBCC. Body Mass Index, serum sex hormones, and breast Cancer risk in Postmenopausal Women, JNCI: J Natl Cancer Inst, vol 95, no. 16, pp. 1218–26.

  54. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer, N Engl J Med, vol 354, no. 3, pp. 270–82.

Download references

Acknowledgements

We appreciate the Shahid Beheshti University of Medical Sciences and Hormozgan University of Medical Sciences for their financial support of this study. The authors express their appreciation to all of the participants of this study.

Funding

This project was funded by a grant from the Shahid Beheshti University of Medical Sciences, Tehran, Iran. The funding body has no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Author information

Authors and Affiliations

  1. Endocrinology and Metabolism Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

    Mitra Kazemi Jahromi

  2. Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    Asal Neshatbini Tehrani & Zeinab Heidari

  3. Department of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    Asal Neshatbini Tehrani

  4. Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Hossein Farhadnejad, Hamid Ahmadirad, Farshad Teymoori, Niloufar Saber & Parvin Mirmiran

  5. The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran

    Hadi Emamat

  6. Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran

    Farshad Teymoori

  7. Department of Community Nutrition, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Bahram Rashidkhani

Authors
  1. Mitra Kazemi Jahromi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Asal Neshatbini Tehrani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hossein Farhadnejad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hadi Emamat
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hamid Ahmadirad
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Farshad Teymoori
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zeinab Heidari
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Niloufar Saber
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bahram Rashidkhani
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Parvin Mirmiran
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MKJ and FT contributed to conceptualizing and designing the current study. HE and HF analyzed and interpreted the data. AN, FT, and HA drafted the initial manuscript. P M, Z H, N.S, and B R contributed to the revision of the manuscript. HF and FT supervised the project. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Farshad Teymoori or Bahram Rashidkhani.

Ethics declarations

Ethics approval and consent to participate

Informed written consent was obtained from participants. All procedures performed in studies involving human participants adhered to the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The ethics research committee approved the study’s protocol of the Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Consent for publication

Not applicable.

Conflict of interest

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jahromi, M.K., Tehrani, A.N., Farhadnejad, H. et al. Dietary advanced glycation end products are associated with an increased risk of breast cancer in Iranian adults. BMC Cancer 23, 932 (2023). https://doi.org/10.1186/s12885-023-11462-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12885-023-11462-5

Keywords

BMC Cancer

ISSN: 1471-2407

Contact us